Views | |
---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 83 |
June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | |
---|---|---|---|---|---|---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 3 | 0 | 3 | 1 | 3 | 2 | 0 |
Views | |
---|---|
2021_Zirngibl_etal.pdf | 120 |